Skip to content

Shattuck Labs, Inc. STTK Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
5M
Zymeworks logo
ZymeworksZYME
100M0.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
10M0.0%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
10M

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s convertible preferred stock authorized shares?
Shattuck Labs, Inc. (STTK) reported convertible preferred stock authorized shares of 10M in Q1 2026.
How has Shattuck Labs, Inc.'s convertible preferred stock authorized shares changed year-over-year?
Shattuck Labs, Inc.'s convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
What is the long-term trend for Shattuck Labs, Inc.'s convertible preferred stock authorized shares?
Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.